New stomach cancer drugs are increasing, but companion diagnostics are 'one drug, one test'... Stomach cancer society 'compatibility recognition' needed
위암 신약 늘어나는데 동반진단은 '1약 1검사'…위암학회 "호환성 인정해야"
Reports
- 위암 신약 늘어나는데 동반진단은 '1약 1검사'…위암학회 "호환성 인정해야"New stomach cancer drugs are increasing, but companion diagnostics are 'one drug, one test'... Stomach cancer society 'compatibility recognition' neededbosa.co.kr · ko ·